Covered recipient · General Payments record
SHANE E THORESON
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$1,620.28
- Reported across 111 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $210.03 | 13 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $61.51 | 4 |
| Lilly USA, LLC | $35.93 | 2 |
| Novo Nordisk AS | $33.67 | 2 |
| PFIZER INC. | $27.97 | 2 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $19.27 | 1 |
| Acerta Pharma LLC | $16.73 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $14.95 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (13)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $13.42 | 01/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106223091 | CMS |
| ABBVIE INC. | $15.05 | 04/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106223093 | CMS |
| ABBVIE INC. | $16.86 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106223095 | CMS |
| ABBVIE INC. | $16.18 | 09/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106223097 | CMS |
| AstraZeneca Pharmaceuticals LP | $16.73 | 08/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105775402 | CMS |
| Lilly USA, LLC | $17.61 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135373536 | CMS |
| Lilly USA, LLC | $18.32 | 08/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135405216 | CMS |
| Novartis Pharmaceuticals Corporation | $19.27 | 10/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087439962 | CMS |
| Novo Nordisk Inc | $16.97 | 04/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097425168 | CMS |
| Novo Nordisk Inc | $16.70 | 12/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097402256 | CMS |
| PFIZER INC. | $14.09 | 01/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131442025 | CMS |
| PFIZER INC. | $13.88 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131567668 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $14.95 | 01/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137687688 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.